Post-Marketing non-interventional safety evaluation of obizur in the treatment of bleeding episodes for patients with acquired hemophilia A

August 09, 2018
https://clinicaltrials.gov/ct2/show/NCT02610127
Hematology Non Malignant
Principal Investigator: Philip Kuriakose, MD

Acquired hemophilia A

Accepting Participants